Chronic Spontaneous Urticaria (Chronic Hives)

Chronic Spontaneous Urticaria (Chronic Hives)

young woman with Chronic Hives

Skin Care Research is enrolling participants for a Chronic Spontaneous Urticaria (chronic hives) clinical trial in Dallas, TX. Qualified participants will receive all study-related care provided by board-certified dermatologists at one of our partnered clinics. All Skin Care Research studies are in compliance with FDA guidelines and uphold the highest clinical standards. 

To Qualify:

⦁ Must be 18 years and older
⦁ Must have a history of itch and hives for ≥ 8 consecutive weeks
⦁ No history of anaphylaxis
⦁ Be willing to travel to our Dallas, TX locations (transportation may be provided)

To learn more, fill out a form on this page or call 561-948-3116 


Chronic Spontaneous Urticaria Clinical Trials: What is Chronic Spontaneous Urticaria?

Chronic spontaneous urticaria (CSU), also known as chronic idiopathic urticaria, is a skin condition characterized by the recurrent appearance of hives (urticaria) that persist for more than six weeks without an identifiable cause. Urticaria, commonly known as hives, are red, raised, itchy welts on the skin that can vary in size and shape and may come and go over time.

CSU is considered “spontaneous” because the hives appear without any identifiable triggers or external stimuli. It can significantly impact a person’s quality of life due to its chronic and unpredictable nature, leading to discomfort, sleep disturbances, and emotional stress.

Learn more

About Skin Care Research

As a clinical research center with over 25 years of experience in the execution of dermatological and cosmetic clinical trials, Skin Care Research has conducted hundreds of successful research studies for trusted brands including Abbvie, Eli Lilly, Galderma, Pfizer Inc, and more. Our research staff and board-certified dermatologists are highly trained and experienced in conducting FDA approved clinical trials. 

Skin Care Research conducts phase 2 through phase 4 clinical trials with patient safety being the number one priority. To learn more about our enrolling studies, including time commitment, participant responsibilities, and other things you should expect, fill out the form or give us a call at 561-948-3116.